Kamal Cheema, MD
Clinical Cardiac Electrophysiology · Springfield, MONPI 1962885715
Payments from drug & device makers
What this record shows
This record is dominated by grants: $28,250 of the $29,852 with a category attached, or 94.6%. Medtronic accounts for 74.8% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2022 at $17,043 and has fallen 98.0% since, to $337 in 2025.
Across 35 payments — averaging $852.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$22K
- Abbott$7K
- Boston Scientific$350
- Biosense Webster, Inc.$218
- Edwards Lifesciences$127
- Kestra Medical Technology Services, Inc.$46
- plus $22 from 1 others
What the payments were for
- Grants$28,25095%
- Food & beverage$1,2504%
- Education$3521%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 15 | $22,340 |
| Abbott | 2 | $6,750 |
| Boston Scientific | 10 | $350 |
| Biosense Webster, Inc. | 4 | $218 |
| Edwards Lifesciences | 1 | $127 |
| Kestra Medical Technology Services, Inc. | 2 | $46 |
| Heartflow, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$29,852 in reported general payments places this provider in the 70th percentile of 74 clinical cardiac electrophysiology providers in Missouri.
See all clinical cardiac electrophysiology providers in Missouri →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 93 | $62,227 |
| XareltoRivaroxaban | 17 | $9,559 |
| Amiodarone Hcl | 49 | $952 |
| Metoprolol Succinate | 52 | $376 |
| Flecainide Acetate | 14 | $352 |
| Metoprolol Tartrate | 38 | $118 |
| Warfarin Sodium | 21 | $111 |
| Carvedilol | 30 | $84 |
| Potassium Chloride | 20 | $76 |
| Lisinopril | 32 | $65 |
| Furosemide | 18 | $41 |
Paid to pharmacies, not to this prescriber.
Other clinical cardiac electrophysiology in Springfield
- Shang-Chiun LeeSpringfield$50K
- Sunthosh ParvathaneniSpringfield$43K
- John GarnerSpringfield$35K
- Indrajeet MahataSpringfield$24K
- Jian Liang TanSpringfield$13K
- Scott FerreiraSpringfield$6K
- Stanley WigginsSpringfield$5K
- Phillip CuculichSaint Louis$473K
- Sanjaya GuptaKansas City$316K
- Daniel CooperSaint Louis$168K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.